Table of Contents
ISRN Nephrology
Volume 2013 (2013), Article ID 394582, 9 pages
http://dx.doi.org/10.5402/2013/394582
Review Article

New Biomarkers for the Quick Detection of Acute Kidney Injury

Department of Urology, Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Tevfik Saglam Street No. 11, Zuhuratbaba, 3400 Istanbul, Turkey

Received 11 September 2012; Accepted 6 October 2012

Academic Editors: M. Léone, D. Malhotra, and D. G. Struijk

Copyright © 2013 Abdulmuttalip Simsek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Lameire, W. Van Biesen, and R. Vanholder, “The changing epidemiology of acute renal failure,” Nature Clinical Practice Nephrology, vol. 2, no. 7, pp. 364–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Avasthi, J. S. Sandhu, and K. Mohindra, “Acute renal failure in medical and surgical intensive care units—a one year prospective study,” Renal Failure, vol. 25, no. 1, pp. 105–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. J. Hoste, N. H. Lameire, R. C. Vanholder, D. D. Benoit, J. M. A. Decruyenaere, and F. A. Colardyn, “Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome,” Journal of the American Society of Nephrology, vol. 14, no. 4, pp. 1022–1030, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. P. Ympa, Y. Sakr, K. Reinhart, and J. L. Vincent, “Has mortality from acute renal failure decreased? A systematic review of the literature,” American Journal of Medicine, vol. 118, no. 8, pp. 827–832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, “Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group,” Critical Care, vol. 8, no. 4, pp. R204–R212, 2004. View at Google Scholar · View at Scopus
  6. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, article R31, 2007. View at Google Scholar · View at Scopus
  7. The Kidney Disease Improving Global Outcomes (KDIGO) Working Group, “Definition and classification of acute kidney injury,” Kidney International, supplement 2, pp. 19–36, 2012. View at Google Scholar
  8. S. M. Bagshaw, C. George, and R. Bellomo, “A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients,” Nephrology Dialysis Transplantation, vol. 23, no. 5, pp. 1569–1574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. L. A. Stevens, R. A. Lafayette, R. D. Perrone et al., “Laboratory evaluation of kidney function,” in Diseases of the Kidney and Urinary Tract, R. W. Schrier, Ed., Lippincott, Williams and Wilkins, Philadelphia, Pa, USA, 8th edition, 2007. View at Google Scholar
  10. R. A. Star, “Treatment of acute renal failure,” Kidney International, vol. 54, no. 6, pp. 1817–1831, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. A. F. Michael, S. V. Vishal, and V. B. Joseph, “Biomarkers in acute kidney injury,” in Biomarkers in Renal Disease, H. R. Mitchell and O. Mark, Eds., Nova Science, New York, NY, USA, 2008. View at Google Scholar
  12. K. M. Schmidt-Ott, K. Mori, Y. L. Jau et al., “Dual action of neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 407–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Mishra, M. A. Qing, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. R. McIlroy, G. Wagener, and H. T. Lee, “Biomarkers of acute kidney injury: an evolving domain,” Anesthesiology, vol. 112, no. 4, pp. 998–1004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Mori, H. T. Lee, D. Rapoport et al., “Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 610–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Mishra, K. Mori, Q. Ma, C. Kelly, J. Barasch, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity,” American Journal of Nephrology, vol. 24, no. 3, pp. 307–315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Mishra, C. Dent, R. Tarabishi et al., “Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery,” The Lancet, vol. 365, no. 9466, pp. 1231–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. I. Fadel, A. M. O. Abdel Rahman, M. F. Mohamed et al., “Plasma neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury after cardio-pulmonary bypass in pediatric cardiac surgery,” Archives of Medical Science, vol. 8, no. 2, pp. 250–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Zappitelli, K. K. Washburn, A. A. Arikan et al., “Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study,” Critical Care, vol. 11, article R84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Devarajan, “Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 241, pp. 89–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Krawczeski, J. G. Woo, Y. Wang, M. R. Bennett, Q. Ma, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass,” Journal of Pediatrics, vol. 158, no. 6, pp. 1009–e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Wagener, M. Jan, M. Kim et al., “Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery,” Anesthesiology, vol. 105, no. 3, pp. 485–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Koyner, M. R. Bennett, E. M. Worcester et al., “Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery,” Kidney International, vol. 74, no. 8, pp. 1059–1069, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Wagener, G. Gubitosa, S. Wang, N. Borregaard, M. Kim, and H. T. Lee, “Urinary neutrophil-associated lipocalin and acute kidney injury after cardiac surgery,” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 425–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Haase-Fielitz, R. Bellomo, P. Devarajan et al., “Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-A prospective cohort study,” Critical Care Medicine, vol. 37, no. 2, pp. 553–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Haase, R. Bellomo, P. Devarajan et al., “The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury,” Annals of Thoracic Surgery, vol. 88, no. 1, pp. 124–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Haase-Fielitz, R. Bellomo, P. Devarajan et al., “The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury,” Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3349–3354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. E. Perry, J. D. Muehlschlegel, K. Y. Liu et al., “Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients,” Anesthesia and Analgesia, vol. 110, no. 6, pp. 1541–1547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Tuladhar, V. O. Püntmann, M. Soni, P. P. Punjabi, and R. G. Bogle, “Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass,” Journal of Cardiovascular Pharmacology, vol. 53, no. 3, pp. 261–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Devarajan, “NGAL in Acute Kidney Injury: from Serendipity to Utility,” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 395–399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Bachorzewska-Gajewska, J. Malyszko, E. Sitniewska, J. S. Malyszko, and S. Dobrzycki, “Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions,” American Journal of Nephrology, vol. 26, no. 3, pp. 287–292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Bachorzewska-Gajewska, B. Poniatowski, and S. Dobrzycki, “NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine,” Advances in Medical Sciences, vol. 54, no. 2, pp. 221–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. O. G. Shaker, A. El-Shehaby, and M. El-Khatib, “Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography,” Angiology, vol. 61, no. 8, pp. 731–736, 2010. View at Google Scholar · View at Scopus
  34. R. Hirsch, C. Dent, H. Pfriem et al., “NGAL is an early predictive biomarker of contrast-induced nephropathy in children,” Pediatric Nephrology, vol. 22, no. 12, pp. 2089–2095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Gaspari, P. Cravedi, M. Mandalà et al., “Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study,” Nephron—Clinical Practice, vol. 115, no. 2, pp. c154–c160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-D. Park, J.-Y. Seo, and S.-Y. Lee, “The Relationship between serum neutrophil gelatinase-associated lipocalin and renal function in patients with vancomycin treatment,” Annals of Clinical and Laboratory Science, vol. 42, no. 1, pp. 7–13, 2012. View at Google Scholar
  37. A. Wasilewska, W. Zoch-Zwierz, K. Taranta-Janusz, and J. Michaluk-Skutnik, “Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?” Pediatric Nephrology, vol. 25, no. 5, pp. 889–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. S. Wheeler, P. Devarajan, Q. Ma et al., “Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock,” Critical Care Medicine, vol. 36, no. 4, pp. 1297–1303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. H. N. Yang, C. S. Boo, M. G. Kim, S. K. Jo, W. Y. Cho, and H. K. Kim, “Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury,” American Journal of Nephrology, vol. 31, no. 6, pp. 501–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. H. R. H. De Geus, J. Bakker, E. M. E. H. Lesaffre, and J. L. M. L. Le Noble, “Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 7, pp. 907–914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. E. D. Siew, L. B. Ware, T. Gebretsadik et al., “Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults,” Journal of the American Society of Nephrology, vol. 20, no. 8, pp. 1823–1832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. D. N. Cruz, M. De Cal, F. Garzotto et al., “Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population,” Intensive Care Medicine, vol. 36, no. 3, pp. 444–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Bagshaw, M. Bennett, M. Haase et al., “Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness,” Intensive Care Medicine, vol. 36, no. 3, pp. 452–461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Constantin, E. Futier, S. Perbet et al., “Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study,” Journal of Critical Care, vol. 25, no. 1, pp. 176.e1–176.e6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Lentini, M. De Cal, A. Clementi, A. D'Angelo, and C. Ronco, “Sepsis and AKI in ICU patients: the Role of plasma biomarkers,” Critical Care Research and Practice, vol. 2012, Article ID 856401, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. H. Endre, J. W. Pickering, R. J. Walker et al., “Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function,” Kidney International, vol. 79, no. 10, pp. 1119–1130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. H. R. de Geus, J.G. Woo, and Y. Urinary, “Neutrophil gelatinase-associated lipocalin measured on admission to the intensive care,” Nephron Extra, vol. 1, no. 1, pp. 9–23, 2011. View at Google Scholar
  48. J. Mårtensson, M. Bell, A. Oldner, S. Xu, P. Venge, and C. R. Martling, “Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury,” Intensive Care Medicine, vol. 36, no. 8, pp. 1333–1340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. E. Hollmen, L. E. Kyllönen, K. A. Inkinen, M. L. T. Lalla, J. Merenmies, and K. T. Salmela, “Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study,” Critical Care, vol. 15, no. 3, article R121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. C. R. Parikh, A. Jani, J. Mishra et al., “Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation,” American Journal of Transplantation, vol. 6, no. 7, pp. 1639–1645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. I. E. Hall, S. G. Yarlagadda, S. G. Coca et al., “IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation,” Journal of the American Society of Nephrology, vol. 21, no. 1, pp. 189–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Ichimura, J. V. Bonventre, V. Bailly et al., “Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury,” The Journal of Biological Chemistry, vol. 273, no. 7, pp. 4135–4142, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, “Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury,” American Journal of Physiology, vol. 290, no. 2, pp. F517–F529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. V. S. Vaidya, G. M. Ford, S. S. Waikar et al., “A rapid urine test for early detection of kidney injury,” Kidney International, vol. 76, no. 1, pp. 108–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Ichimura, E. J. P. V. Asseldonk, B. D. Humphreys, L. Gunaratnam, J. S. Duffield, and J. V. Bonventre, “Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells,” The Journal of Clinical Investigation, vol. 118, no. 5, pp. 1657–1668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, “Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury,” Kidney International, vol. 62, no. 1, pp. 237–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Ichimura, C. C. Hung, S. A. Yang, J. L. Stevens, and J. V. Bonventre, “Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury,” American Journal of Physiology, vol. 286, no. 3, pp. F552–F563, 2004. View at Google Scholar · View at Scopus
  58. P. Espandiari, J. Zhang, B. A. Rosenzweig et al., “The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity,” Toxicological Sciences, vol. 99, no. 2, pp. 637–648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. W. C. Prozialeck, V. S. Vaidya, J. Liu et al., “Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity,” Kidney International, vol. 72, no. 8, pp. 985–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Zhou, V. S. Vaidya, R. P. Brown et al., “Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium,” Toxicological Sciences, vol. 101, no. 1, pp. 159–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Vinken, S. Starckx, and E. Barale-Thomas, “Tissue kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats,” Toxicologic Pathology, vol. 40, no. 7, pp. 1049–1062, 2012. View at Google Scholar
  62. W. K. Han, G. Wagener, Y. Zhu, S. Wang, and H. T. Lee, “Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 873–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. J. L. Koyner, V. S. Vaidya, M. R. Bennett et al., “Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2154–2165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. O. Liangos, M. C. Perianayagam, V. S. Vaidya et al., “Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure,” Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 904–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. M. M. van Timmeren, M. C. van den Heuvel, V. Bailly, S. J. L. Bakker, H. van Goor, and C. A. Stegeman, “Tubular kidney injury molecule-1 (KIM-1) in human renal disease,” Journal of Pathology, vol. 212, no. 2, pp. 209–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Malyszko, E. Koc-Zorawska, J. S. Malyszko, and M. Mysliwiec, “Kidney injury molecule-1 correlates with kidney function in renal allograft recipients,” Transplantation Proceedings, vol. 42, no. 10, pp. 3957–3959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. C. C. Szeto, B. C. H. Kwan, K. B. Lai et al., “Urinary expression of kidney injury markers in renal transplant recipients,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2329–2337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Westhuyzen, “Cystatin C: a promising marker and predictor of impaired renal function,” Annals of Clinical and Laboratory Science, vol. 36, no. 4, pp. 387–394, 2006. View at Google Scholar · View at Scopus
  69. S. Herget-Rosenthal, G. Marggraf, J. Hüsing et al., “Early detection of acute renal failure by serum cystatin C,” Kidney International, vol. 66, no. 3, pp. 1115–1122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Herget-Rosenthal, S. Trabold, F. Pietruck, M. Holtmann, T. Philipp, and A. Kribben, “Cystatin C: efficacy as screening test for reduced glomerular filtration rate,” American Journal of Nephrology, vol. 20, no. 2, pp. 97–102, 2000. View at Google Scholar · View at Scopus
  71. K. Jung and M. Jung, “Cystatin C: a promising marker of glomerular filtration rate to replace creatinine,” Nephron, vol. 70, no. 3, pp. 370–371, 1995. View at Google Scholar · View at Scopus
  72. D. J. Newman, H. Thakkar, R. G. Edwards et al., “Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine,” Kidney International, vol. 47, no. 1, pp. 312–318, 1995. View at Google Scholar · View at Scopus
  73. D. Stickle, B. Cole, K. Hock, K. A. Hruska, and M. G. Scott, “Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population,” Clinical Chemistry, vol. 44, no. 6, pp. 1334–1338, 1998. View at Google Scholar · View at Scopus
  74. L. Risch, A. Blumberg, and A. R. Huber, “Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates,” Renal Failure, vol. 23, no. 3-4, pp. 439–448, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Finney, D. J. Newman, H. Thakkar, J. M. E. Fell, and C. P. Price, “Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children,” Archives of Disease in Childhood, vol. 82, no. 1, pp. 71–75, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Grubb, J. Björk, V. Lindström, G. Sterner, P. Bondesson, and U. Nyman, “A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 65, no. 2, pp. 153–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Grubb, U. Nyman, J. Björk et al., “Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children,” Clinical Chemistry, vol. 51, no. 8, pp. 1420–1431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. D. Herrero-Morín, S. Málaga, N. Fernández et al., “Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children,” Critical Care, vol. 11, article R59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Spahillari, C. R. Parikh, K. Sint et al., “Serum cystatin C-versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study,” American Journal of Kidney Diseases. In press.
  80. M. G. Shlipak, S. G. Coca, Z. Wang et al., “Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery,” American Journal of Kidney Diseases, vol. 58, no. 3, pp. 366–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Manetti, E. Pardini, M. Genovesi et al., “Thyroid function differently affects serum cystatin C and creatinine concentrations,” Journal of Endocrinological Investigation, vol. 28, no. 4, pp. 346–349, 2005. View at Google Scholar · View at Scopus
  82. L. Risch, R. Herklotz, A. Blumberg, and A. R. Huber, “Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients,” Clinical Chemistry, vol. 47, no. 11, pp. 2055–2059, 2001. View at Google Scholar · View at Scopus
  83. L. Risch and A. R. Huber, “Glucocorticoids and increased serum cystatin C concentrations,” Clinica Chimica Acta, vol. 320, no. 1-2, pp. 133–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. I. E. Hall, J. L. Koyner, M. D. Doshi, R. J. Marcus, and C. R. Parikh, “Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation,” American Journal of Nephrology, vol. 33, no. 5, pp. 407–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. V. Y. Melnikov, T. Ecder, G. Fantuzzi et al., “Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure,” The Journal of Clinical Investigation, vol. 107, no. 9, pp. 1145–1152, 2001. View at Google Scholar · View at Scopus
  86. V. Y. Melnikov, S. Faubel, B. Siegmund, M. Scott Lucia, D. Ljubanovic, and C. L. Edelstein, “Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice,” The Journal of Clinical Investigation, vol. 110, no. 8, pp. 1083–1091, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. Z. He, L. Lu, C. Altmann et al., “Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury,” American Journal of Physiology, vol. 295, no. 5, pp. F1414–F1421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Wu, M. L. Craft, P. Wang et al., “IL-18 contributes to renal damage after ischemia-reperfusion,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2331–2341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Wang, Q. Long, W. Zhang, and N. Chen, “Protective effects of exogenous interleukin 18-binding protein in a rat model of acute renal ischemia-reperfusion injury,” Shock, vol. 37, no. 3, pp. 333–340, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. Z. He, B. Dursun, D. J. Oh, L. Lu, S. Faubel, and C. L. Edelstein, “Macrophages are not the source of injurious interleukin-18 in ischemic acute kidney injury in mice,” American Journal of Physiology, vol. 296, no. 3, pp. F535–F542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. C. L. Edelstein, T. S. Hoke, H. Somerset et al., “Proximal tubules from caspase-1-deficient mice are protected against hypoxia-induced membrane injury,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1052–1061, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. C. R. Parikh, A. Jani, V. Y. Melnikov, S. Faubel, and C. L. Edelstein, “Urinary interleukin-18 is a marker of human acute tubular necrosis,” American Journal of Kidney Diseases, vol. 43, no. 3, pp. 405–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. I. Striz, K. Eliska, H. Eva et al., “Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft,” Immunology Letters, vol. 99, no. 1, pp. 30–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. C. R. Parikh, E. Abraham, M. Ancukiewicz, and C. L. Edelstein, “Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit,” Journal of the American Society of Nephrology, vol. 16, no. 10, pp. 3046–3052, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. E. D. Siew, T. A. Ikizler, T. Gebretsadik et al., “Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 8, pp. 1497–1505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  96. K. K. Washburn, M. Zappitelli, A. A. Arikan et al., “Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children,” Nephrology Dialysis Transplantation, vol. 23, no. 2, pp. 566–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. C. R. Parikh, J. Mishra, H. Thiessen-Philbrook et al., “Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery,” Kidney International, vol. 70, no. 1, pp. 199–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. C. R. Parikh, P. Devarajan, M. Zappitelli et al., “Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1737–1747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. C. R. Parikh, S. G. Coca, H. Thiessen-Philbrook et al., “Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery,” Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1748–1757, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Yokoyama, A. Kamijo-Ikemori, T. Sugaya, S. Hoshino, T. Yasuda, and K. Kimura, “Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage,” American Journal of Pathology, vol. 174, no. 6, pp. 2096–2106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. E. Noiri, K. Doi, K. Negishi et al., “Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury,” American Journal of Physiology, vol. 296, no. 4, pp. F669–F679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Yamamoto, E. Noiri, Y. Ono et al., “Renal L-type fatty acid-binding protein in acute ischemic injury,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2894–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Negishi, E. Noiri, K. Doi et al., “Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury,” American Journal of Pathology, vol. 174, no. 4, pp. 1154–1159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. D. Portilla, C. Dent, T. Sugaya et al., “Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery,” Kidney International, vol. 73, no. 4, pp. 465–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Katagiri, K. Doi, K. Honda et al., “Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery,” Annals of Thoracic Surgery, vol. 93, no. 2, pp. 577–583, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. T. Nakamura, T. Sugaya, and H. Koide, “Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion,” Shock, vol. 31, no. 5, pp. 454–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. K. Doi, E. Noiri, R. Maeda-Mamiya et al., “Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury,” Critical Care Medicine, vol. 38, no. 10, pp. 2037–2042, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Li, M. Zhu, Q. Xia et al., “Urinary neutrophil gelatinase-associated lipocalin and L-type fatty acid binding protein as diagnostic markers of early acute kidney injury after liver transplantation,” Biomarkers, vol. 17, no. 4, pp. 336–342, 2012. View at Publisher · View at Google Scholar · View at Scopus